Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type
Clinical trial NCT02248116 · TERMINATED
Trial details
- NCT number
- NCT02248116
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1999-05-01
- Primary completion
- 2000-09-01
- Enrollment
- 198
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.